Trademark: 90605633
Word
ACCURADX
Status Date
Tuesday, February 13, 2024
Filing Date
Friday, March 26, 2021
Published for Opposition
Tuesday, December 19, 2023
9 Downloadable computer software for bioinformatics analyses of NGS data for research use only and medical diagnostic purposes via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs)
5 genetics, genomics and epigenomics-related reagents for medical diagnostic purposes via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs)
1 genetics, genomics and epigenomics-related reagents for research use, including for nucleic acid and protein sample preparation for next-generation sequencing (NGS)
42 Scientific research, scientific analytical research and scientific research consulting services in the field of next-generation sequencing (NGS) and sample preparation therefor, performance for NGS, DNA and RNA mapping technologies including KAS-seq, Keth-seq, CAP-C, and assisting researchers using of NGS technologies; scientific research services regarding DNA and RNA mapping technologies including KAS-seq, Keth-seq, CAP-C; scientific research consulting services in the field of assisting researchers using of NGS technologies; scientific research, scientific analytical research and scientific research consulting services in the field of medical diagnoses via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs); software as a service (SAAS) services featuring analytic software platforms focusing on bioinformatics analyses of NGS data for research use only and future medical diagnostic purposes via laboratory-developed tests (LDTs) and FDA-approved in vitro diagnostics (IVDs)
The mark consists of the wording "ACCURADX" with a DNA symbol partially circling the letters "DX".
Feb 13, 2024
Noa E-Mailed - Sou Required From Applicant
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Published For Opposition
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Nov 15, 2023
Approved For Pub - Principal Register
Nov 7, 2023
Examiner's Amendment Entered
Nov 7, 2023
Notification Of Examiners Amendment E-Mailed
Nov 7, 2023
Examiners Amendment E-Mailed
Nov 7, 2023
Examiners Amendment -Written
Oct 18, 2023
Teas/Email Correspondence Entered
Oct 17, 2023
Correspondence Received In Law Office
Oct 17, 2023
Teas Request For Reconsideration Received
Aug 4, 2023
Notification Of Final Refusal Emailed
Aug 4, 2023
Final Refusal E-Mailed
Aug 4, 2023
Final Refusal Written
Apr 5, 2023
Suspension Checked - To Attorney For Action
Aug 24, 2022
Notification Of Letter Of Suspension E-Mailed
Aug 24, 2022
Letter Of Suspension E-Mailed
Aug 24, 2022
Suspension Letter Written
Jul 7, 2022
Assigned To Examiner
May 7, 2022
Teas/Email Correspondence Entered
May 6, 2022
Correspondence Received In Law Office
May 6, 2022
Teas Response To Office Action Received
Nov 10, 2021
Notification Of Non-Final Action E-Mailed
Nov 10, 2021
Non-Final Action E-Mailed
Nov 10, 2021
Non-Final Action Written
Nov 4, 2021
Assigned To Examiner
Jul 2, 2021
Notice Of Design Search Code E-Mailed
Jul 1, 2021
New Application Office Supplied Data Entered
Mar 30, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
